Skip to main content
SpringerLink
Log in

Kontrolluntersuchungen unter Therapie mit Psychopharmaka

  • Chapter
Grundlagen der Neuro-Psychopharmakologie

Zusammenfassung

Kontrolluntersuchungen sind unter Therapie mit Psychopharmaka prinzipiell sinnvoll, sie nehmen in den letzten Jahren aufgrund intensivierter Pharmakovigilanzprojekte immer mehr Raum ein, werden aber auch wegen haftungs- rechtlicher Fragen unverzichtbar.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aichhorn W, Huber R, Stuppaeck C et al. (2006) Cardiomyopathy after long-term treatment with lithium — more than a coincidence? J Psychopharmacol 20: 589–591

    Article  CAS  PubMed  Google Scholar 

  • Alper K, Schwartz KA, Kolts RL et al. (2007b) Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 62: 345–354

    Article  PubMed  Google Scholar 

  • Alper K, Schwartz KA, Kolts RL et al. (2007a) Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA summary basis of approval reports. Biol Psychiatry 62: 345–354

    Article  PubMed  Google Scholar 

  • American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004a) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27: 596–601

    Article  Google Scholar 

  • American Diabetes Association American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004b) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27: 596–601

    Article  Google Scholar 

  • Antonini A, Poewe W (2007) Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson’s disease. Lancet Neurol 6: 826–829

    Article  CAS  PubMed  Google Scholar 

  • Arizona Center for Education and Research on Therapeutics (2007) http://www.torsades.org/medical-pros/ drug-lists/browse-drug-list.cfm

    Google Scholar 

  • Awad SS, Miskulin J, Thompson N (2003) Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg 27: 486–488

    Article  PubMed  Google Scholar 

  • Bardow A, Nyvad B, Nauntofte B (2001) Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ. Arch Oral Biol 46: 413–423

    Article  CAS  PubMed  Google Scholar 

  • Baumgartner C (2001) Die einzelnen Antiepileptika. In: Beaulieu C, editor. Handbuch der Epilepsien. Klinik, Diagnostik, Therapie und psychosoziale Aspekte., Springer-Verlag New York, S 310–387

    Google Scholar 

  • Bender S, Grohmann R, Engel RR, Degner D, Ttmann-Balcar A, Ruther E (2004) Severe adverse drug reactions in psychiatric inpatients treated with neu-roleptics. Pharmacopsychiatry 37 Suppl 1: 46–53

    Google Scholar 

  • Benkert O., Hippius H (2007) Kompendium der Psychiatrischen Pharmakotherapie. 6. Aufage. Springer Medizin Verlag Heidelberg

    Google Scholar 

  • Beydoun A, Sackellares JC, Shu V (1997) Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group. Neurology 48: 182–188

    Article  CAS  PubMed  Google Scholar 

  • Bjornsson E, Nordlinder H, Olsson R (2006) Clinical characteristics and prognostic markers in disulfiram-induced liver injury. J Hepatol 44: 791–797

    Article  PubMed  Google Scholar 

  • Bradwejn J, Ahokas A, Stein DJ et al. (2005) Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study. Br J Psychiatry 187: 352–359

    Article  PubMed  Google Scholar 

  • Degner D, Grohmann R, Kropp S et al. (2004)Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 37 Suppl 1: 39–45

    Google Scholar 

  • Dose M, Emrich HM (2002) Kontrolluntersuchungen. In: Riederer P, Laux G, Pöldinger W, editors. Neuropsychopharmaka Antidepressiva und Phasen-prophylaktika. 2. Auf., Springer-Verlag Wien New York, S 858–889

    Google Scholar 

  • Drici MD, Priori S (2007) Cardiovascular risks of atypical antipsychotic drug treatment. Pharmacoepidemiol Drug Saf 16: 882–890

    Article  CAS  PubMed  Google Scholar 

  • Egger C, Muehlbacher M, Nickel M et al. (2006) A review on hyponatremia associated with SSRIs, reboxetine and venlafaxine. International Journal of Psy chiatry in Clinical Practice 10: 17–26

    Article  CAS  Google Scholar 

  • Glassman AH, Bigger JT (2001) Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 158: 1774–1782

    Article  CAS  PubMed  Google Scholar 

  • Goodheart RS, Dunne JW, Edis RH (1991) Phenelzine associated peripheral neuropathy — clinical and electrophysiologic findings. Aust N Z J Med 21: 339–340

    Article  CAS  PubMed  Google Scholar 

  • Goodwin FK, Jamison KR (2007) Maintenance Medical Treatment. Manic Depressive Illness: Bipolar Diosders and Recurrent Depression. 2 ed., Oxford University Press New York, S 797–848

    Google Scholar 

  • Hanje AJ, Pell LJ, Votolato NA et al. (2006) Case report: fulminant hepatic failure involving duloxetine hydrochloride. Clin Gastroenterol Hepatol 4: 912–917

    Article  PubMed  Google Scholar 

  • Honigfeld G, Arellano F, Sethi J et al. (1998) Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. J Clin Psychiatry 59 Suppl 3: 3–7

    PubMed  Google Scholar 

  • Joffe H, Cohen LS, Suppes T et al. (2006) Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry 59: 1078–1086

    Article  CAS  PubMed  Google Scholar 

  • Kaschka WP (2002) Kontrolluntersuchungen. In: Riederer P, Laux G, Pöldinger W, editors. Neuropsychopharmaka Antidepressiva und Phasenprophylaktika. 2. Aufl., Springer-Verlag Wien New York, S 848–849

    Google Scholar 

  • Khandwala HM, Van US (2006) Reversible hypercalcemia and hyperparathyroidism associated with lithium therapy: case report and review of literature. Endocr Pract 12: 54–58

    Article  PubMed  Google Scholar 

  • Kirby D, Harrigan S, Ames D (2002) Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry 17: 231–237

    Article  PubMed  Google Scholar 

  • König W (2002) Kontrolluntersuchungen. In: Riederer P, Laux G, Pöldinger W, editors. Neuropsychopharmaka Antidepressiva und Phasenprophylaktika. 2. Auf., Springer-Verlag Wien New York, S 198–202

    Google Scholar 

  • König W, Laux G (1998) Kontrolluntersuchungen. In: Riederer P, Laux G, Pöldinger W, editors. Neuro-Psychopharmaka. Ein Therapie-Handbuch. Band 4: Neuroleptika. 2 ed., Springer-Verlag Wien New York, S 197–201

    Google Scholar 

  • Krishnan KRR (2004) Monoamine Oxidase Inhibitors. In: Schatzberg AF, Nemeroff CB, editors. Textbook of Psychopharmacology. 3 ed., American Psychiatric Publishing Washington, S 303–314

    Google Scholar 

  • Laux G, Dietmaier O (2006) Praktische Psychopharmakotherapie. 5. Aufl. Urban & Fischer, München

    Google Scholar 

  • Marder SR, Wirshing DA (2004) Clozapine. In: Schatzberg AF, Nemeroff CB, editors. Textbook of Psychopharmacology. 3 ed., American Psychiatric Publishing, Arlington, S 443–456

    Google Scholar 

  • Marder SR, Essock SM, Miller AL et al. (2004) Physical health monitoring of patients with schizophrenia. Am J Psychiatry 161: 1334–1349

    Article  PubMed  Google Scholar 

  • McIntyre RS, Soczynska JK, Bordbar K et al. (2007) Antipsychotic-associated Weight Gain. A Synthesis and Clinical Recommadations. In: Bermudes RA, Keck PE, McElroy SL, editors. Managing Metabolic Abnormalities in the Psychiatrically Ill. A Clinical Guide for Psychiatrists. 1 ed., American Psychiatric Publishing, Inc., Arlington, S 165–201

    Google Scholar 

  • Meyer JM (2007) Serum Lipids: Effects of Antipsychotics. In: Bermudes RA, Keck PE, McElroy SL, editors. Managing Metabolic Abnormalities in the Psychiatrically Ill. A Clinical Guide for Psychiatrists., American Psychiatric Publishing inc, Arlington, S 239–277

    Google Scholar 

  • Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J (2005) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 64: 1134–1138

    Article  CAS  PubMed  Google Scholar 

  • Newcomer JW (2004) Metabolic risk during antipsychotic treatment. Clin Ther 26: 1936–1946

    Article  CAS  PubMed  Google Scholar 

  • Newcomer JW (2007) Glucose Metabolism. Effects of Atypical Antipsychotics. In: Bermudes RA, Keck PE, McElroy SL, editors. Managing Metabolic Abnormalities in the Psychiatrically Ill. A Clinical Guide for Psychiatrists., American Psychiatric Publishing Inc., Arlington, S 203–238

    Google Scholar 

  • Nicholas LM, Ford AL, Esposito SM et al. (2003) The effects of mirtazapine on plasma lipid prof les in healthy subjects. J Clin Psychiatry 64: 883–889

    Article  CAS  PubMed  Google Scholar 

  • Nissen SE (2006) ADHD drugs and cardiovascular risk. N Engl J Med 354: 1445–1448

    Article  CAS  PubMed  Google Scholar 

  • Richter CM, Müller-Oerlinghausen B (2000) Labortechnisch erfassbare unerwünschte Arzneimittelwirkungen (UAW). In: Gastpar M, Bangerl I, editors. Laboruntersuchungen in der psychiatrischen Routine. Georg Thieme Verlag, Stuttgart New York, S 91–105

    Google Scholar 

  • Sawant S, Daviss SR (2004) Seizures and prolonged QTc with atomoxetine overdose. Am J Psychiatry 161: 757

    Article  PubMed  Google Scholar 

  • Schatzberg AF, Cole JO, DeBattista C (2007a) Antipsychotic Drugs. Manual of Clinical Psychopharmacology. 6 ed., pp 159–253

    Google Scholar 

  • Schatzberg AF, Cole JO, DeBattista C (2007b) Mood Stabilizers. Manual of Clinical Psychopharmacology. 6 ed., American Psychiatric Publishing, Arlington, S 294–300

    Google Scholar 

  • Schmauss M (2002) Kontrolluntersuchungen. In: Riederer P, Laux G, Pöldinger W, editors. Neuropsychopharmaka Antidepressiva und Phasenprophylaktika. 2. Aufl., Springer-Verlag Wien New York, S 538–542

    Google Scholar 

  • Shahzad S, Suleman MI, Shahab H et al. (2002) Cataract occurrence with antipsychotic drugs. Psychosomatics 43: 354–359

    Article  CAS  PubMed  Google Scholar 

  • Stahl SM, Grady MM, Moret C et al. (2005) SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10: 732–747

    Article  PubMed  Google Scholar 

  • Stanilla JK, Simpson GM (2004) Drugs to Treat Extrapyramidal Side Effects. In: Schatzberg AF, Nemeroff CB, editors. Textbook of Psychopharmacology. 3 ed., American Psychiatric Publishing, Arlington, S 519–546

    Google Scholar 

  • Stubner S, Grohmann R, Engel R et al. (2004) Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry 37 Suppl 1: S 70–78

    Google Scholar 

  • Swanson JM, Elliott GR, Greenhill LL et al. (2007) Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry 46: 1015–1027

    Article  PubMed  Google Scholar 

  • Szarfman A, Tonning JM, Levine JG et al. (2006) Atypical antipsychotics and pituitary tumors: a pharmacovigilance study. Pharmacotherapy 26: 748–758

    Article  CAS  PubMed  Google Scholar 

  • Thompson JW Jr, Ware MR, Blashfield RK (1990) Psychotropic medication and priapism: a comprehensive review. J Clin Psychiatry 51: 430–433

    PubMed  Google Scholar 

  • U.S. Food and Drug Administration (FDA) (2003) www.fda. gov/medwatch/SAFETY/2003/topamax_dhcp.pdf

    Google Scholar 

  • U.S. Food and Drug Administration (FDA) (2007) www. fda.gov/Cder/drug/InfoSheets/HCP/haloperidol.htm

    Google Scholar 

  • Van Amelsvoort T, Bakshi R, Devaux CB et al. (1994) Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia 35: 181–188

    Article  PubMed  Google Scholar 

  • Wiesegger G, Kienbacher C, Pellegrini E et al. (2007) [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders.]. Neuropsychiatr 21: 187–206

    PubMed  Google Scholar 

  • Wilens TE, Prince JB, Spencer TJ (2006) Stimulants and sudden death: what is a physician to do? Pediatrics 118: 1215–1219

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Christian-Doppler-Klinik, Universitätsklinik für Psychiatrie und Psychotherapie I, Ignaz-Harrer-Straße 79, 5020, Salzburg, Österreich

    Univ.-Prof. Dr. Christoph Stuppäck, Prim. Univ.-Doz. Dr. Christian Geretsegger & Dr. Christoph Egger

Authors
  1. Univ.-Prof. Dr. Christoph Stuppäck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prim. Univ.-Doz. Dr. Christian Geretsegger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. Christoph Egger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie, Klinische Neurochemie, Universität Würzburg, Deutschland

    Peter Franz Riederer

  2. Inn-Salzach-Klinikum gGmbH, Fachkrankenhaus für Psychiatrie, Psychotherapie, Psychosomatische Medizin und Neurologie, Wasserburg a. Inn · Rosenheim · Freilassing, Akademisches Lehrkrankenhaus der Ludwig-Maximilians-Universität München, Deutschland

    Gerd Laux

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag/Wien

About this chapter

Cite this chapter

Stuppäck, C., Geretsegger, C., Egger, C. (2010). Kontrolluntersuchungen unter Therapie mit Psychopharmaka. In: Riederer, P.F., Laux, G. (eds) Grundlagen der Neuro-Psychopharmakologie. Springer, Vienna. https://doi.org/10.1007/978-3-211-85473-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-85473-0_12

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-85472-3

  • Online ISBN: 978-3-211-85473-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation